Lantzaki Vasiliki, Fulton Emily A, McLaughlin Mark, Bennet Euan D, Conway Elizabeth A, Ridyard Alison E
University of Glasgow, Glasgow, UK.
Paragon Veterinary Referrals, Wakefield, UK.
J Vet Intern Med. 2025 Mar-Apr;39(2):e70002. doi: 10.1111/jvim.70002.
Urine neutrophil gelatinase-associated lipocalin (uNGAL) is a biomarker for the early diagnosis of AKI.
To evaluate uNGAL in dogs with non-associative immune mediated hemolytic anemia (IMHA) and to evaluate whether uNGAL correlates with disease severity markers, negative prognostic indicators and outcome.
Twenty-two dogs with non-associative IMHA and 14 healthy dogs.
Prospective case-control study. uNGAL was measured by a commercially available ELISA-kit and corrected to urine creatinine (uNGAL to creatinine ratio [UNCR]). uNGAL and UNCR of IMHA cases were compared to that of healthy dogs and the correlation with other clinicopathological markers was evaluated. uNGAL and UNCR were also compared between dogs with a CHAOS or ASA score < 3 and ≥ 3.
uNGAL and UNCR were significantly higher in dogs with IMHA when compared to healthy controls (uNGAL median 114.58 and 0.43 ng/mL, respectively, p < 0.001; UNCR median 174.87 and 0.13 ng/mg, respectively, p < 0.001). uNGAL and UNCR were moderately positively correlated with urea (p = 0.005, r = 0.58, 0.20-0.81 95% CI and p = 0.001, r = 0.64, 0.29-0.84 95% CI, respectively) and total bilirubin (p = 0.003, r = 0.60, 0.22-0.82 95% CI and p = 0.002, r = 0.62, 0.25-0.83 95% CI, respectively). These were also significantly higher in dogs with hemoglobinuria compared to those without (uNGAL: median 269 and 30.99 ng/mL, respectively, p < 0.001; UNCR: median 585.3 and 352 37.47 ng/mg, respectively, p < 0.001). There was no statistically significant difference in uNGAL or UNCR when assessing survival to discharge (p = 0.24 and p = 0.16, respectively, 95% CI).
This study suggests that renal injury might be underappreciated in dogs with IMHA.
尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)是急性肾损伤早期诊断的生物标志物。
评估非相关性免疫介导性溶血性贫血(IMHA)犬的uNGAL,并评估uNGAL是否与疾病严重程度标志物、不良预后指标及预后相关。
22只非相关性IMHA犬和14只健康犬。
前瞻性病例对照研究。采用市售ELISA试剂盒检测uNGAL,并校正为尿肌酐肌酐(uNGAL与肌酐比值[UNCR])。将IMHA病例的uNGAL和UNCR与健康犬进行比较,并评估其与其他临床病理标志物的相关性。还比较了CHAOS或ASA评分<3分和≥3分的犬之间的uNGAL和UNCR。
与健康对照组相比,IMHA犬的uNGAL和UNCR显著更高(uNGAL中位数分别为114.58和0.43 ng/mL,p<0.001;UNCR中位数分别为174.87和0.13 ng/mg,p<0.001)。uNGAL和UNCR与尿素(p=0.005,r=0.58,95%CI为0.20 - 0.81和p=0.001,r=0.64,95%CI为0.29 - 0.84)以及总胆红素(p=0.003,r=0.60,95%CI为0.22 - 0.82和p=0.002,r=0.62,95%CI为0.25 - 0.83)呈中度正相关。与无血红蛋白尿的犬相比,有血红蛋白尿的犬的uNGAL和UNCR也显著更高(uNGAL:中位数分别为269和30.99 ng/mL,p<0.001;UNCR:中位数分别为585.3和37.47 ng/mg,p<0.001)。评估出院生存率时,uNGAL或UNCR无统计学显著差异(p分别为0.24和0.16,95%CI)。
本研究表明,IMHA犬的肾损伤可能未得到充分认识。